fFN Extension Study
January 07, 2019
Andrew Healy, MD
Baystate Medical Center, 759 Chestnut Street, Springfield, MA
The goal of this study is to collect and test additional fFN samples that will support analytical testing and clinical use of the test for evaluating the benefits of measuring fFN from a vaginal fluid specimen taken during early pregnancy (from 16 weeks to 22 weeks) to assess the risk of pre-term birth. Fetal fibronectin (also known as fFN) is a “glue-like” protein that bonds your developing baby to your uterus.
Inclusion: Age ≥18 years, gestational age between 16 weeks 0 days and 21 weeks 6 days, and at high risk for preterm delivery (determined by specific criteria).
Exclusions: Known significant congenital structural or chromosomal fetal anomaly, cerclage at time of specimen collection, vaginal progesterone within 24 hours prior to specimen collection.